Bon Natural Life Ltd (BON) News
Filter BON News Items
BON News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BON News Highlights
- BON's 30 day story count now stands at 2.
- Over the past 17 days, the trend for BON's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about BON are BIO.
Latest BON News From Around the Web
Below are the latest news stories about BON NATURAL LIFE LTD that investors may wish to consider to help them evaluate BON as an investment opportunity.
Bon Natural Life Limited Provides Update on Its Expansion ProjectBon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that there will be a delay to the initial production target of Q4 2022 for its third production site – Yumen Plant to May 2023. |
Traders News Source Senior Editor, Mark Roberts Interviews Richard Hu, CEO Bon Natural Life LimitedTraders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with Bon Natural Life Limited. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday! |
Diamond Equity Research Releases Update Note on Bon Natural Life Limited (NASDAQ: BON)NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on Bon Natural Life Limited (NASDAQ: BON). The update note includes information on Bon Natural Life’s financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The update note is available here. Highlights from the note include: H1 2022 Earnings Update - For the |
Bon Natural Life Limited Announces Record First Half-Year Revenue and Net IncomeBon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-year financial results for the six months ended March 31, 2022. |
Bon Natural Life Limited Announces 2022 Half-Year Earnings Release Date and WebcastBon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, will issue its half-year earnings release for the reporting period ended March 31, 2022 before the market open on Monday, August 1, 2022. |
Bon Natural Life Limited Announces Change to Board CompositionBon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the appointment of Jeffrey Guzy, as a new independent Director to its Board of Directors and as Chair of the Audit Committee, both effective June 28, 2022. Effective June 27, 2022, Mr. Christopher Constable resigned as a director of the Company for personal reasons and stepped down as a member and chairman of t |
We Like These Underlying Return On Capital Trends At Bon Natural Life (NASDAQ:BON)To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to... |
Bon Natural Life Limited Introduces New Powder Drink For Anti-H. Pylori and Digestive HealthBon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that it has launched a new cruciferous vegetable based probiotic powder drink that could potentially inhibit the proliferation of Helicobacter pylori and help regulate the digestive system. The powder drink is the first proprietary product of BON's cruciferous vegetable based health supplement series. |
Diamond Equity Research Initiates Coverage on Bon Natural Life Limited (NASDAQ: BON)NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Bon Natural Life Limited (NASDAQ: BON). The in-depth 22-page initiation report includes detailed information on the Bon Natural Life’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Increasing Focus on Developing Innov |